UTAH MEDICAL PRODUCTS, INC. (UTMD) Gross margin 2016–2025
UTAH MEDICAL PRODUCTS, INC. (UTMD) gross margin by fiscal year — reported gross profit divided by reported revenue.
57.1%FY2025 · since FY2016: 60.3% → 57.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 57.1% | -1.9 pp |
| FY2024 | 59.0% | -0.8 pp |
| FY2023 | 59.8% | -1.8 pp |
| FY2022 | 61.6% | -1.4 pp |
| FY2021 | 63.0% | +2.5 pp |
| FY2020 | 60.6% | -2.3 pp |
| FY2019 | 62.8% | +0.2 pp |
| FY2018 | 62.6% | -1.1 pp |
| FY2017 | 63.7% | +3.5 pp |
| FY2016 | 60.3% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More UTMD financial trends
UTMD RevenueUTMD Net incomeUTMD Net marginUTMD Gross profitUTMD Operating incomeUTMD Operating marginUTMD Operating cash flowUTMD Free cash flowUTMD Capital expendituresUTMD Return on equityUTMD Stock buybacksUTMD Dividends paidUTMD Total assetsUTMD Total liabilitiesUTMD Shareholders’ equityUTMD overview →